Infection News

Results from a real-word study showed fecal microbiota transplantation for Clostridioides difficile infection was highly effective, with little serious adverse events related to the procedure, according to data from Digestive Disease Week.

A new microbiome-based treatment for Clostridioides difficile infection showed success in reducing recurrence of the infection at 8 weeks, according to preliminary results released by the manufacturer.

Patients with multidrug-resistant organisms treated with fecal microbiota transplantation had shorter hospitalizations, fewer infections in their bloodstream and had easier-to-treat infections, according to an expert presenting data during a press conference in advance of Digestive Disease Week data publication.

Neither treatment of nor complete eradication of Helicobacter pylori infection was associated with future Clostridioides difficile infection in a large study of United States veterans, according to research published in The American Journal of Gastroenterology.

The COVID-19 pandemic has been an unprecedented crisis unlike anything seen in many decades. While infectious disease specialists have been on the front lines since the first outbreak of the disease, as more information comes out, the world is beginning to understand the role the gastrointestinal tract plays in the disease.

The first COVID-19 related story concerned with gastroenterology was published in Healio Gastroenterology and Liver Disease on March 6. Since then, we have published more than a dozen articles and posted numerous videos from leaders in the GI community about how the pandemic has impacted clinical practice and how it might change things going forward.

The estimated national burden of Clostridioides difficile infections and related hospitalizations declined between 2011 and 2017 because of a decrease in health care-associated infections, according to findings published in the New England Journal of Medicine.

In this exclusive video series, Stephen B. Hanauer, MD, medical director of the Digestive Health Center at Northwestern University Feinberg School of Medicine, discusses the impact of COVID-19 on the world of gastroenterology. In this video, he told Healio Gastroenterology and Liver Disease about how it has affected patients with inflammatory bowel disease, as well as clinical trials.

Patients who develop new-onset digestive symptoms, like diarrhea, after a possible exposure to COVID-19 should be suspected for the illness, according to research published in The American Journal of Gastroenterology.

In this guest commentary, Farhan Quader, MD, of Washington University School of Medicine, and Zachary Smith, DO, of Case Western Reserve School of Medicine , discuss how endoscopist s should navigate the COVID-19 pandemic.